OMGA - Omega Therapeutics Qarzning balans kapitallashuviga nisbati

Omega Therapeutics, Inc. (OMGA) kompaniyasining korporativ logotipi

Omega Therapeutics sanoat gigantlaridan olingan avanslar va mRNA terapiyasi uchun patent huquqlari asosida daromad keltiradi. Ekologik strategiya markazlar uchun energiyani tejash va emissiyalarni filtrlashni o'z ichiga oladi. Kompaniya onkologiyaga qarshi epigenetik dori vositalarini ishlab chiqadi. Qarzning kapitalga nisbati o'zgarishlari tarixi moliyaviy risklarni vizuallashtiradi, 0.00 esa joriy metrika qiymatini shakllantiradi.

OMGA (Omega Therapeutics Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 08.03.2025gacha

Omega Therapeutics Inc (OMGA) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Omega Therapeutics|OMGA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Omega Therapeutics Corp|OMGA - Korxonaning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Omega Therapeutics|OMGA - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati omegatherapeutics.com|OMGA - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Omega Therapeutics|OMGA - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Omega|OMGA - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Omega Therapeutics Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:OMGA, Omega Therapeutics
Omega Therapeutics Inc tayyor mahsulotlari

Ko'rsatkich dinamikasi majburiyatlarning kapitalning bozor qiymatiga nisbatining sezgirligi bilan belgilanadi. Ushbu metrika qarz yuklamasi darajasini o'lchab, moliyaviy barqarorlikni va haddan tashqari kredit yuklamasi xavfini baholash imkonini beradi. Omega Therapeutics (OMGA) uchun qarzlar balansi OMEGA platformasining ishlab chiqilishi va klinik sinovlarini moliyalashtirishda hal qiluvchi ahamiyatga ega. Ushbu nisbatni optimallashtirish pul oqimi uzilishlari xavfini minimallashtiradi. Umumiy qarzning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investor epigenetik tadqiqotlarni xizmat ko'rsatishning real xarajatlarini ko'rishi mumkin.

Omega Therapeutics (OMGA) raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|qiagen.com - Balans kapitallashuviga qarzlar|IONS (Ionis) - Qarzning balans kapitallashuviga nisbati|RGEN: Balans qiymatiga qarzlar|RNA (Avidity) - Qarzning balans kapitallashuviga nisbati|CRISPR (CRSP) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar ultragenyx.com|BEAM: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Sarepta Therapeutics (SRPT)|Balans kapitallashuviga qarzlar TWST (Twist Bio)|TXG - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Intellia Therapeutics (NTLA)|stoketherapeutics.com (STOK) - Qarzning sof aktivlarga nisbati|BLFS - Qarzning balans qiymatiga nisbati|Wave Life Sciences Ltd (WVE) - Qarzning balans kapitaliga nisbati|MAZE - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Sionna Corp|Prime Medicine, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar TSHA (tayshagtx.com)|Qarzning balans kapitallashuviga nisbati uniQure|Qarzning sof aktivlarga nisbati MeiraGTx Holdings MGTX|Regenxbio - Balans kapitallashuviga qarzlar|SLDB: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Ocugen, Inc. (OCGN)|pacb.com (PACB) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar BNTC (Benitec Biopharma)|Balans qiymatiga qarzlar Design Therapeutics Inc (DSGN)|Qarzning balans qiymatiga nisbati RCKT|Balans kapitallashuviga qarzlar 4D Molecular Corp FDMT|Qarzning balans qiymatiga nisbati Lexeo Therapeutics, Inc. (LXEO)|Qarzning balans kapitaliga nisbati Korro Bio Inc. KRRO|Balans kapitallashuviga qarzlar EDIT (Editas Medicine)|SLN - Sof aktivlarga qarzlar|PRQR (proqr.com) - Balans kapitallashuviga qarzlar|CDXS (Codexis) - Qarzning balans qiymatiga nisbati|SGMO: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar NAUT|Metagenomi - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar DTIL (Precision BioSciences Inc.)|Generation Bio - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Boundless Bio Inc BOLD|Balans kapitallashuviga qarzlar XCUR|IMNN - Qarzning sof aktivlarga nisbati|PHIO: Balans kapitallashuviga qarzlar|Mustang Bio (MBIO) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar TransCode Therapeutics Inc. (RNAZ)|Qarzning balans qiymatiga nisbati BNGO|Qarzning balans kapitallashuviga nisbati Applied DNA Sciences APDN|Qarzning balans qiymatiga nisbati bluebirdbio.com (BLUE)|Balans kapitallashuviga qarzlar IPA (ImmunoPrecise Antibodies Ltd.)|Singular Genomics Systems, Inc. - Balans kapitallashuviga qarzlar|RGLS (Regulus Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|SYRS: Balans qiymatiga qarzlar|TBIO (Telesis Bio, Inc.) - Qarzning balans kapitallashuviga nisbati|traconpharma.com (TCON) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UBX (Unity Biotechnology, Inc.)